This HTML5 document contains 113 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34483567
rdf:type
wikibase:Item
schema:description
מאמר מדעי artigo científico (publicado na 2006) artykuł naukowy 2006年论文 2006年論文 научна статия мақолаи илмӣ wissenschaftlicher Artikel artículo científico publicado en 2006 2006 թվականի հունվարին հրատարակված գիտական հոդված 2006 թուականի Յունուարին հրատարակուած գիտական յօդուած 2006년 논문 artikull shkencor 2006年论文 mokslinis straipsnis scienca artikolo article scientifique (publié 2006) artículu científicu espublizáu en 2006 article scientific artigo científico 2006年論文 2006 nî lūn-bûn vědecký článek artigo científico (publicado na 2006) 2006年論文 naučni članak vitskapeleg artikkel wetenschappelijk artikel 2006年论文 научни чланак articol științific videnskabelig artikel (udgivet 2006) 2006年论文 სამეცნიერო სტატია article científic bilimsel makale مقالهٔ علمی vetenskaplig artikel научни чланак บทความทางวิทยาศาสตร์ tudományos cikk 2006年論文 bài báo khoa học 2006年論文 научная статья سائنسی مضمون наукова стаття, опублікована в січні 2006 vitenskapelig artikkel artikulong pang-agham 2006年论文 scientific article مقالة علمية vedecký článok teaduslik artikkel tieteellinen artikkeli articolo scientifico 2006年论文 2006年の論文 επιστημονικό άρθρο мақолаи илмӣ ২০০৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ
p:P577
wds:Q34483567-7CCFACE4-AF5B-410E-B13A-0CD68B265B50
wdt:P577
2006-01-01T00:00:00Z
p:P407
wds:Q34483567-CC4722C8-91A9-425F-A9FB-98076CB5101C
wdt:P407
wd:Q1860
p:P2093
wds:Q34483567-AC6D6D2C-0FFE-4915-AE2C-659644A345FE wds:Q34483567-D79E7D19-BA23-4E0A-AA3D-4EC9C6A0A55F wds:Q34483567-235D5A5F-830D-45AD-A88B-7EDB70B41CE1
wdt:P2093
Michael W Lee John D McConnell William R Noble
rdfs:label
Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater
skos:prefLabel
Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater
schema:name
Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater
p:P50
wds:Q34483567-E8AAFD22-1B19-4DB5-A9D5-A1E944D8750A wds:Q34483567-B0D31ADE-D3A0-4C0D-85C7-A4440A39598D wds:Q34483567-C0B3FF9B-E42A-4C80-9BB1-17F35852E6CE wds:Q34483567-C1BEB00A-3238-456D-A16B-31D29AED3851 wds:Q34483567-A95AA8EB-9FE5-4EE4-926F-D202AD1CAD01 wds:Q34483567-013943A7-7EB7-4D3F-A114-032BD1B3BEC0
wdt:P50
wd:Q117223164 wd:Q88176270 wd:Q114079290 wd:Q114079291 wd:Q57640405 wd:Q114079299
p:P1476
wds:Q34483567-78FF846A-1D3C-4619-A9F7-BE0E535FB234
wdt:P1476
Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater
p:P304
wds:Q34483567-CCAA5569-B91B-4E25-ACAB-470499521049
wdt:P304
217-20; discussion 220-1
p:P31
wds:Q34483567-A611357E-646F-4C0B-AFE8-2B2EF16C1AE7
wdt:P31
wd:Q13442814
p:P921
wds:Q34483567-66017DF3-F630-4675-83AB-1840929DF066
wdt:P921
wd:Q506659
p:P698
wds:Q34483567-4FEABE0C-E927-4E5C-8CD0-62124B1435A0
wdtn:P698
n6:16406915
wdt:P698
16406915
p:P1433
wds:Q34483567-AFEE4159-E841-4269-B7A6-C73484709059
wdt:P1433
wd:Q15709979
p:P433
wds:Q34483567-346BE924-3149-4234-8F56-2584A2BC9871
p:P478
wds:Q34483567-FEF2CA2E-625A-461D-B25C-C26C62BA4939
wdt:P433
1
wdt:P478
175
p:P356
wds:Q34483567-4DCB368C-1FBE-45D0-AEE2-1144D643D722
wdtn:P356
n11:S0022-5347(05)00041-8
wdt:P356
10.1016/S0022-5347(05)00041-8